The shares of VEON Ltd. (NASDAQ:VEON) has been pegged with a rating of Neutral by Goldman in its latest research note that was published on October 12th, 2018. Goldman wasn’t the only research firm that published a report of VEON Ltd., with other equities research analysts also giving their opinion on the stock. HSBC Securities advised investors in its research note published on August 20th, 2018, to Buy the VEON stock. The stock had earned Buy rating from Goldman when it published its report on July 6th, 2018. The stock was given Overweight rating by JP Morgan in its report released on July 3rd, 2018. HSBC Securities was of a view that VEON is Hold in its latest report on March 8th, 2018. Goldman thinks that VEON is worth Neutral rating. This was contained in the firm’s report on February 8th, 2018.

Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 5 believe it has the potential for further growth, thus rating it as Hold while 4 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $3.65. The price of the stock the last time has raised by 10.14% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 51.04.

The shares of the company added by 1.33% during the trading session on Wednesday, reaching a low of $2.24 while ending the day at $2.28. During the trading session, a total of 18.79 million shares were traded which represents a -267.77% decline from the average session volume which is 5.11M shares. VEON had ended its last session trading at 2.25. VEON Ltd. currently has a market cap of $4.03B while its P/E earnings growth sits at 0.44, with a beta of 1.80. VEON Ltd. debt-to-equity ratio currently stands at 2.14, while its quick ratio hovers at 0.70. VEON 52-week low price stands at $2.07 while its 52-week high price is $3.14.

The company in its last quarterly report recorded $0.01 earnings per share which is below the $0.02 predicted by most analysts. The VEON Ltd. generated $2,249.00 million in revenue during the last quarter, which is slightly higher than the $2,215.14 million predicted by analysts. In the second quarter last year, the firm recorded $0.52 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -5100%. VEON Ltd. has the potential to record -0.23 EPS for the current fiscal year, according to equities analysts.

Investment analysts at BofA/Merrill published a research note on April 12th, 2019 where it informed investors and clients that Chevron Corporation (NYSE:CVX) is now rated as Buy. Their price target on the stock stands at $140. HSBC Securities also rated CVX as Upgrade on August 20th, 2018, with its price target of $140 suggesting that CVX could surge by 12.68% from its current share price. Even though the stock has been trading at $121.17/share, analysts expect it to surge higher by -0.74% to reach $137.73/share. It started the day trading at $122.54 and traded between $120.05 and $120.27 throughout the trading session.

A look at its technical shows that CVX’s 50-day SMA is 122.24 while its 200-day SMA stands at 118.84. The stock has a high of $131.08 for the year while the low is $100.22. The company’s P/E ratio currently sits at 15.55, while the P/B ratio is 1.47. At the moment, only of Chevron Corporation shares were sold short. The company’s average trading volume currently stands at 6.79M shares, which means that the short-interest ratio is just 2.83 days. Over the past seven days, the company moved, with its shift of -4.16%. Looking further, the stock has raised 7.96% over the past 90 days while it gained 2.85% over the last six months.

The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more CVX shares, increasing its portfolio by +3.09% during the last quarter. This move now sees The Vanguard Group Inc purchasing 4,544,230 shares in the last quarter, thus it now holds 151,691,557 shares of CVX, with a total valuation of $18,685,365,991. SSgA Funds Management Inc meanwhile sold more CVX shares in the recently filed quarter, changing its stake to $14,139,664,182 worth of shares. BlackRock Fund Advisors followed the path by increasing its CVX portfolio by +5.96% in the quarter. This means that BlackRock Fund Advisors bought 5,114,905 shares in the last quarter and now controls 90,899,595 shares of the CVX stock, with the valuation hitting $11,197,012,112.

Similarly, Capital Research Management Co increased its Chevron Corporation shares by +15.11% during the recently filed quarter. After buying 3,589,113 shares in the last quarter, the firm now controls 27,346,896 shares of Chevron Corporation which are valued at $3,368,590,649. In the same vein, Northern Trust Investments Inc increased its Chevron Corporation shares by during the most recent reported quarter. The firm bought 563,450 shares during the quarter which increased its stakes to 26,710,573 shares and is now valued at $3,290,208,382. Following these latest developments, around 0.05% of Chevron Corporation stocks are owned by institutional investors and hedge funds.